These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8862430)

  • 1. Vaccination with herpes simplex virus type 1 glycoprotein K impairs clearance of virus from the trigeminal ganglia resulting in chronic infection.
    Ghiasi H; Cai S; Nesburn AB; Wechsler SL
    Virology; 1996 Oct; 224(1):330-3. PubMed ID: 8862430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Either a CD4(+)or CD8(+)T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice.
    Ghiasi H; Perng G; Nesburn AB; Wechsler SL
    Microb Pathog; 1999 Dec; 27(6):387-94. PubMed ID: 10588911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific and nonspecific immune stimulation of MHC-II-deficient mice results in chronic HSV-1 infection of the trigeminal ganglia following ocular challenge.
    Ghiasi H; Perng GC; Hofman FM; Cai S; Nesburn AB; Wechsler SL
    Virology; 1999 Jun; 258(2):208-16. PubMed ID: 10366558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
    Ellison AR; Yang L; Voytek C; Margolis TP
    Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-dependent enhancement of HSV-1 infection by anti-gK sera.
    Ghiasi H; Perng GC; Nesburn AB; Wechsler SL
    Virus Res; 2000 Jul; 68(2):137-44. PubMed ID: 10958985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
    Frye TD; Chiou HC; Hull BE; Bigley NJ
    Arch Virol; 2002 Sep; 147(9):1747-59. PubMed ID: 12209314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis.
    Branco FJ; Fraser NW
    J Virol; 2005 Jul; 79(14):9019-25. PubMed ID: 15994795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1.
    Morrison LA; Knipe DM
    Virology; 1996 Jun; 220(2):402-13. PubMed ID: 8661391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-consensus branch point plays an important role in determining the stability of the 2-kb LAT intron during acute and latent infections of herpes simplex virus type-1.
    Mukerjee R; Kang W; Suri V; Fraser NW
    Virology; 2004 Jul; 324(2):340-9. PubMed ID: 15207620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins.
    Ghiasi H; Bahri S; Nesburn AB; Wechsler SL
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1352-60. PubMed ID: 7775113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A replication competent HSV-1(McKrae) with a mutation in the amino-terminus of glycoprotein K (gK) is unable to infect mouse trigeminal ganglia after cornea infection.
    Saied AA; Chouljenko VN; Subramanian R; Kousoulas KG
    Curr Eye Res; 2014 Jun; 39(6):596-603. PubMed ID: 24401006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons.
    Valyi-Nagy T; Olson SJ; Valyi-Nagy K; Montine TJ; Dermody TS
    Virology; 2000 Dec; 278(2):309-21. PubMed ID: 11118355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ; Morrison LA; Knipe DM
    Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.
    Ghaemi A; Soleimanjahi H; Bamdad T; Soudi S; Arefeian E; Hashemi SM; Ebtekar M
    Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):197-210. PubMed ID: 17335902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations.
    Ghiasi H; Cai S; Slanina S; Nesburn AB; Wechsler SL
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1213-21. PubMed ID: 9152241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of Signal Peptide Peptidase, an Essential Herpes Simplex Virus 1 Glycoprotein K Binding Partner, Reduces Virus Infectivity
    Wang S; Ghiasi H
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate and acquired immunity to herpes simplex virus type 1.
    Halford WP; Veress LA; Gebhardt BM; Carr DJ
    Virology; 1997 Sep; 236(2):328-37. PubMed ID: 9325240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.
    Osorio Y; Ghiasi H
    J Virol; 2005 Mar; 79(6):3297-308. PubMed ID: 15731224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of interleukin (IL)-2 and IL-4 in herpes simplex virus type 1 ocular replication and eye disease.
    Ghiasi H; Cai S; Slanina SM; Perng GC; Nesburn AB; Wechsler SL
    J Infect Dis; 1999 May; 179(5):1086-93. PubMed ID: 10191208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia.
    Maggioncalda J; Mehta A; Su YH; Fraser NW; Block TM
    Virology; 1996 Nov; 225(1):72-81. PubMed ID: 8918535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.